Common Contracts
1 similar Clinical Study Site Agreement contracts
ContractClinical Study Site Agreement • June 14th, 2017
AMENDMENT NO. 1TO CLINICAL STUDY SITE AGREEMENTPROTOCOL NUMBER MLN0002SC-3027 This Amendment No. 1 to Clinical Study Site Agreement (“Amendment”), effective as of the date of the last signature below, is entered into by and between: Nemocnice Tábor, a.s., located at kpt. Jaroše 2000, 390 03 Tábor, Czech Republic, Company ID no.: 26095203, Tax ID no.: CZ26095203,represented by Ing. Ivo Houška, MBA, Chairman of the Board of Directors, and MUDr. Jana Chocholová,Vice-Chairman of the Board of Directors (“Institution”), Quintiles Czech Republic, s.r.o. located at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00,Identification number: 247 68 651, registered in the Commercial Register of Městský soud v Praze, section C, insert 172751, represented by Alasdair MacDonald (“CRO”) for the purpose of amending the Clinical Study Site Agreement among Institution and CRO dated 20 July 2016 (the “Agreement”) relating to the conduct of the clinical research (the “Study”) described in the protocol en
